weight loss glp 1 comparison glp-1 agonists vs bariatric surgery Metabolic and versus glucagon-like glp-1 gip medications muscle loss

Effect of Linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial

Zhao Y, Xie Y, Li W

Clinical trials show that approximately 70% of weight loss returns within one year after stopping treatment, though individual outcomes vary significantly based on genetic factors and sustained behavioral changes

Additionally, IGF-1 enhances expression and activity of enzymes involved in fatty acid metabolism, including carnitine palmitoyltransferase-1, the rate-limiting enzyme for fatty acid entry into mitochondria for oxidation

[21] Golubkoca A, Leiva T, Snyder K, Schlegel C, Bonvicino SM, Agbaga MP, et al